"The 21st World Pharmaceutical Raw Materials China Exhibition" (CPHI China 2023) was held in Shanghai New International Expo Center from June 19 to 21, 2023. The exhibition attracted many exhibitors from all over the world, covering many fields such as apis, intermediates, and medical devices. As a well-known company in the industry, Sichuan Bohaoda biological carrying company mainly promoted the product inositol to participate in the exhibition.
It is understood that the exhibition area of the exhibition will reach 200,000 square meters, attracting more than 3,000 enterprises to participate, more than 55,000 people at home and abroad to participate, the organizer invited more than 400 industry experts to join, around the latest domestic and foreign policies, forward-looking technology innovation and market access principles and other practical topics for detailed interpretation and analysis. To build a more in-depth social platform for pharmaceutical companies in China and the world and create more opportunities.
In the exhibition, Bohaoda booth welcomed many customers at home and abroad to visit, met many new customers who trust Bohaoda inositol products and reached initial cooperation intention, and also carried out in-depth exchanges with old customers who have cooperated for many years, from the direction of intermediates, additives, application fields, contract customization, etc., to provide customers with a full range of intimate services. Find a win-win way of high-quality development.
Sichuan Bohaoda Biology is a global high-tech company focusing on global biotechnology research and investment, synthetic biology research and development, production and sales. Founded in December 2018 with a registered capital of 100 million yuan, the company has won the title of Sichuan Province specialized and special new, National high-tech Enterprise, and has a number of innovative technologies with enzyme catalytic preparation of inosiol as the core.
Today, Boda celebrates its 5th anniversary. In the past five years, Bohaoda people have continuously innovated, adopted pollution-free and low-energy green production methods to replace the traditional high-pollution and high-energy phytic acid hydrolyzed inositol production methods, and achieved leap-forward changes in inositol product quality, process energy saving and production cost saving. Through the expansion and extension of the industrial chain, Bohaoda is expanding the market value, promoting the formation and development of green biological industry clusters, and providing customers with better services and high-quality products. At the same time, Bohaoda will also strengthen market expansion and brand promotion, improve the company's visibility and influence, and make greater contributions to the cause of human health.
